Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy +/- Metformin in Locally Advanced NSCLC
NCT02186847Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Aug 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in non-small cell lung cancer (NSCLC), sponsored by NRG Oncology. Started Aug 2014; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02186847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186847.